|
Market Closed -
Euronext Paris
11:55:00 2026-09-01 am EDT
|
After hours 01:53:38 pm | |||
| 76.86 EUR | +0.07% |
|
77.14 | +0.36% |
| 11:30am | Regeneron Seen Weighing Expanded Sanofi Deal, RBC Says | MT |
| 07:51am | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| Market Cap | 92.02B 107B 86.56B 78.86B 148B 10,125B 149B 1,023B 398B 5,150B 401B 392B 17,077B | P/E 2026 * |
12.2x | P/E 2027 * | 10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 103B 120B 97.34B 88.68B 167B 11,385B 168B 1,151B 448B 5,791B 450B 441B 19,203B | EV / Sales 2026 * |
2.17x | EV / Sales 2027 * | 1.97x |
| Free-Float |
88.34% | Yield 2026 * |
5.54% | Yield 2027 * | 5.86% |
Last Transcript : Sanofi
| 1 day | +0.07% | ||
| 1 week | -2.39% | ||
| Current month | +0.07% | ||
| 1 month | +3.17% | ||
| 3 months | +3.64% | ||
| 6 months | -5.64% | ||
| Current year | -7.08% |
| 1 week | 76.43 | 79.36 | |
| 1 month | 73.63 | 79.36 | |
| Current year | 71.25 | 84.97 | |
| 1 year | 71.25 | 91.15 | |
| 3 years | 71.25 | 110.88 | |
| 5 years | 71.25 | 110.88 | |
| 10 years | 62.88 | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 2023-09-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/14/26 | Sell | General Counsel | -14,562 | 0.0012% | ||
| 7/6/26 | Others | Executive/Senior Manager | 55,000 | 0.0045% | ||
| 5/31/26 | Buy | Executive/Senior Manager | 27 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.07% | -2.39% | -9.25% | -22.06% | 107B | ||
| +0.77% | -5.51% | +58.55% | +109.23% | 1,031B | ||
| +1.36% | -1.66% | +50.85% | +67.38% | 641B | ||
| +1.24% | -2.48% | +22.31% | +74.90% | 453B | ||
| -1.50% | -7.04% | +33.55% | +33.94% | 349B | ||
| +6.25% | +2.04% | +28.97% | +46.57% | 290B | ||
| -0.07% | -4.12% | +0.95% | +11.79% | 252B | ||
| +0.52% | -2.37% | +50.48% | +68.19% | 232B | ||
| +0.51% | -4.52% | -19.50% | -54.83% | 201B | ||
| +1.39% | -0.34% | +31.54% | +93.42% | 181B | ||
| Average | +0.95% | -2.87% | +24.85% | +42.85% | 373.66B | |
| Weighted average by Cap. | +0.96% | -3.91% | +36.38% | +63.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.68B 55.28B 44.85B 40.86B 76.84B 5,246B 77.26B 530B 206B 2,669B 208B 203B 8,849B | 50.81B 58.9B 47.79B 43.54B 81.88B 5,590B 82.32B 565B 220B 2,844B 221B 216B 9,429B |
| Net income | 7.91B 9.17B 7.44B 6.78B 12.75B 870B 12.82B 87.97B 34.24B 443B 34.43B 33.69B 1,468B | 9.24B 10.72B 8.7B 7.92B 14.9B 1,017B 14.98B 103B 40.01B 517B 40.23B 39.36B 1,715B |
| Net Debt | 11.46B 13.28B 10.78B 9.82B 18.46B 1,261B 18.56B 127B 49.59B 641B 49.87B 48.79B 2,126B | 8.3B 9.63B 7.81B 7.12B 13.38B 914B 13.45B 92.34B 35.94B 465B 36.14B 35.36B 1,541B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-01 | €76.86 | +0.07% | 1,718,967 |
| 26-08-31 | €76.81 | -0.57% | 2,863,251 |
| 26-08-28 | €77.25 | -0.04% | 1,056,025 |
| 26-08-27 | €77.28 | -1.29% | 1,124,375 |
| 26-08-26 | €78.29 | -0.57% | 1,244,940 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
















